New stent aims to prevent uterine scarring in women
NCT ID NCT07611474
First seen May 29, 2026 · Last updated Jun 23, 2026 · Updated 4 times
Summary
This study tests a new uterine stent to prevent intrauterine adhesions (scar tissue) after surgery in women aged 20-40. 200 participants will be randomly assigned to receive either the new stent or standard care (uterine ring, balloon, and gel). The goal is to see if the stent reduces scarring and is safe to use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRAUTERINE ADHESION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Third Xiangya Hospital of Central South University
RECRUITINGChangsha, Hunan, 410013, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
uterine stent (device)
What this could lead to
If it works, this could offer a simpler, safer way to prevent scar tissue in the uterus after surgery, helping preserve fertility.
What could go wrong
This is an early-stage trial with only 200 participants, so results may not apply to everyone. The device might not work better than current methods.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.